Article
Toll-like receptor-4 signaling: a new potential therapeutic pathway for rheumatoid arthritis.
Rheumatology international - 1 Nov 2014
Li Xiaofeng, Xu Tao, Wang Yarui, Huang Cheng, Li Jun
Abstract excerpt
The Toll-like receptor-4 signaling (TLR-4) has been found to be over-expressed in rheumatoid arthritis (RA) synovium. Furthermore, it regulates the expression of pro-inflammatory cytokines. Based on the current evidences, TLR-4 may be a new potential therapeutic pathway for RA.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
